APA (7th ed.) Citation

EA, I., FH, G., MP, W., AA, P., CF, M., O, N., . . . LM, W. (2023). Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level. The Journal of clinical endocrinology and metabolism, 108(11), 2990. https://doi.org/10.1210/clinem/dgad230

Chicago Style (17th ed.) Citation

EA, Imel, et al. "Burosumab Vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level." The Journal of Clinical Endocrinology and Metabolism 108, no. 11 (2023): 2990. https://doi.org/10.1210/clinem/dgad230.

MLA (9th ed.) Citation

EA, Imel, et al. "Burosumab Vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level." The Journal of Clinical Endocrinology and Metabolism, vol. 108, no. 11, 2023, p. 2990, https://doi.org/10.1210/clinem/dgad230.